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Abstract
Cognitive abilities and disorders unique to humans are thought to result from adaptively driven changes in brain
transcriptomes, but little is known about the role of cis-regulatory changes affecting transcription start sites (TSS). Here, we
mapped in human, chimpanzee, and macaque prefrontal cortex the genome-wide distribution of histone H3 trimethylated
at lysine 4 (H3K4me3), an epigenetic mark sharply regulated at TSS, and identified 471 sequences with human-specific
enrichment or depletion. Among these were 33 loci selectively methylated in neuronal but not non-neuronal chromatin
from children and adults, including TSS at DPP10 (2q14.1), CNTN4 and CHL1 (3p26.3), and other neuropsychiatric
susceptibility genes. Regulatory sequences at DPP10 and additional loci carried a strong footprint of hominid adaptation,
including elevated nucleotide substitution rates and regulatory motifs absent in other primates (including archaic
hominins), with evidence for selective pressures during more recent evolution and adaptive fixations in modern
populations. Chromosome conformation capture at two neurodevelopmental disease loci, 2q14.1 and 16p11.2, revealed
higher order chromatin structures resulting in physical contact of multiple human-specific H3K4me3 peaks spaced 0.5–1 Mb
apart, in conjunction with a novel cis-bound antisense RNA linked to Polycomb repressor proteins and downregulated
DPP10 expression. Therefore, coordinated epigenetic regulation via newly derived TSS chromatin could play an important
role in the emergence of human-specific gene expression networks in brain that contribute to cognitive functions and
neurological disease susceptibility in modern day humans.
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Introduction
Cognitive abilities and psychiatric diseases unique to modern
humans could be based on genomic features distinguishing our brain
cells, including neurons, from those of other primates. Because
protein coding sequences for synaptic and other neuron-specific genes
are highly conserved across the primate tree [1,2], a significant
portion of hominid evolution could be due to DNA sequence changes
involving regulatory and non-coding regions at the 59 end of genes
[3,4]. Quantifying these differences, however, is ultimately a daunting
task, considering that, for example, the chimpanzee–human genome
comparison alone reveals close to 356106 single bp and 56106 multi-
bp substitutions and insertion/deletion events [3]. While a large
majority of these are likely to reflect genetic drift and are deemed
‘‘non-consequential’’ with respect to fitness, the challenge is to identify
the small subset of regulatory sequence alterations impacting brain
function and behavior.
Here, we combine comparative genomics and population
genetics with genome-scale comparisons for histone H3-
trimethyl-lysine 4 (H3K4me3), an epigenetic mark sharply
regulated at transcription start sites (TSS) and the 59 end of
transcriptional units in brain and other tissues [5–8] that is
stably maintained in brain specimens collected postmortem
[7,9]. Our rationale to focus on TSS chromatin was also
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guided by the observation that the human brain, and in
particular the cerebral cortex, shows distinct changes in gene
expression, in comparison to other primates [10]. While there is
emerging evidence for an important role of small RNAs shaping
human-specific brain transcriptomes via posttranscriptional mech-
anisms [11] and increased recruitment of recently evolved genes
during early brain development [12], the role of TSS and other cis-
regulatory mechanisms remains unclear. Here, we report that cell
type-specific epigenome mapping in prefrontal cortex (PFC, a type
of higher order cortex closely associated with the evolution of the
primate brain) revealed hundreds of sequences with human-specific
H3K4me3 enrichment in neuronal chromatin, as compared to two
other anthropoid primates, the chimpanzee and the macaque.
These included multiple sites carrying a strong footprint of hominid
evolution, including accelerated nucleotide substitution rates
specifically in the human branch of the primate tree, regulatory
motifs absent in non-human primates and archaic hominins
including Homo neanderthalensis and H. denisova, and evidence for
adaptive fixations in modern day humans. The findings presented
here provide the first insights into human-specific modifications of
the neuronal epigenome, including evidence for coordinated
epigenetic regulation of sites separated by megabases of interspersed
sequence, which points to a significant intersect between evolution-
ary changes in TSS function, species-specific chromatin landscapes,
and epigenetic inheritance.
Results
H3K4me3 Landscapes across Cell Types and Species
The present study focused on the rostral dorsolateral PFC,
including cytoarchitectonic Brodmann Area BA10 and the
immediately surrounding areas. These brain regions represent a
higher association cortex subject to disproportionate morpholog-
ical expansion during primate evolution [13], and are involved in
cognitive operations important for informed choice and creativity
[14,15], among other executive functions. Given that histone
methylation in neuronal and non-neuronal chromatin is differen-
tially regulated at thousands of sites genome-wide [7], we avoided
chromatin studies in tissue homogenates because glia-to-neuron
ratios are 1.4- to 2-fold higher in mature human PFC as compared
to chimpanzee and macaque [16]. Instead, we performed cell
type-specific epigenome profiling for each of the three primate
species, based on NeuN (‘‘neuron nucleus’’) antigen-based
immunotagging and fluorescence-activated sorting, followed by
deep sequencing of H3K4me3-tagged neuronal nucleosomes.
Prefrontal H3K4me3 epigenomes from NeuN+ nuclei of 11
humans, including seven children and four adults [7], were
compared to four chimpanzees and three macaques of mature age
(Table S1). Sample-to-sample comparison, based on a subset of
highly conserved Refseq TSS with one mismatch maximum/
36bp, consistently revealed the highest correlations between
neuronal epigenomes from the same species (Table S2). Strikingly,
however, the H3K4me3 landscape in human neurons was much
more similar to chimpanzee and macaque neurons, when
compared to non-neuronal (NeuN2) cells [7] from the same
specimen/donor or to blood (Figure 1A). Therefore, PFC
neuronal epigenomes, including their histone methylation land-
scapes at TSS, carry a species-specific signature, but show an even
larger difference when compared to their surrounding glial and
other NeuN2 cells.
Several Hundred Loci Show Human-Specific Gain, or
Loss, of Histone Methylation in PFC Neurons
To identify loci with human-specific H3K4me3 enrichment in
PFC neurons, we screened 34,639 H3K4me3 peaks that were at
least 500 bp long and showed a consistent .2-fold H3K4me3
increase for the 11 humans as compared to the average of the
seven chimps and macaques and (ii) minimum length of 500 bp.
We identified 410 peaks in the human genome (HG19) with
significant enrichment compared to the two non-human primate
species (with reads also mapped to HG19) after correcting for false
discovery (FDR), and we call these peaks ‘‘HP’’ hereafter for
‘‘human-specific peaks’’ (Figure 1D; Table S3). We had previously
reported that infant and child PFC neurons tend to have stronger
peaks at numerous loci, compared to the adult [7]. To better age-
match the human and non-human primate cohorts, we therefore
repeated the analysis with our entire, recently published cohort of
nine adult humans without known neurological or psychiatric
disease [7,8]. Using the same set of filter criteria (.2-fold increase
in humans compared to chimpanzees and macaques), we
identified 425 peaks and 296 of them overlapped with the original
410 HP (Table S3). Furthermore, 345 of the 410 peaks overlapped
with the overlapped with the peaks with .1.5-fold increase for
nine adult humans (compared to non-human primates; with
correction for FDR) (Table S4), indicating that HPs can be
detected reliably.
To obtain human depleted peaks we used a reciprocal approach
where initial peaks were detected in chimpanzee and macaque.
For the original cohort of 11 children and adult humans, this
resulted in 61 peaks with a significant, at least 2-fold depletion in
Author Summary
Primate and human genomes comprise billions of base
pairs, but we are unlikely to gain a deeper understanding
of brain functions unique to human (including cognitive
abilities and psychiatric diseases) merely by comparing
linear DNA sequences. Such determinants of species-
specific function might instead be found in the so-called
‘‘epigenetic’’ characteristics of genomic regions; differenc-
es in the protein-packaged chromatin state in which
genomic DNA exists in the cell. Here, we examine neurons
from the prefrontal cortex, a brain region closely associ-
ated with the evolution of the primate brain, and identify
hundreds of short DNA sequences defined by human-
specific changes in chromatin structure and function when
compared to non-human primates. These changes includ-
ed species-specific regulation of methylation marks on the
histone proteins around which genomic DNA is wrapped.
Sequences subject to human-specific epigenetic regula-
tion showed significant spatial clustering, and despite
being separated by hundreds of thousands of base pairs
on the linear genome, were in direct physical contact with
each other through chromosomal looping and other
higher order chromatin features. This observation raises
the intriguing possibility that coordinated epigenetic
regulation via newly derived chromatin features at gene
transcription start sites could play an important role in the
emergence of human-specific gene expression networks in
the brain. Finally, we identified a strong genetic footprint
of hominid evolution in a small subset of transcription start
sites defined by human-specific gains in histone methyl-
ation, with particularly strong enrichment in prefrontal
cortex neurons. For example, the base pair sequence of
DPP10 (a gene critically important for normal human brain
development) not only showed distinct human-specific
changes, but also evidence for more recent selective
pressures within the human population.
Epigenome Mapping in Prefrontal Cortex
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human PFC neurons (Table S5). 50 peaks defined by human-
specific depletion in the mixed cohort of 11 children and adults
were part of the total of 177 peaks with .1.5-fold decrease in the
cohort of nine adults (compared to each of the two non-human
primate species; Table S6). From this, we conclude that at least
471 loci in the genome of PFC neurons show robust human-
specific changes (gain, 410; loss, 61) in histone methylation across a
very wide postnatal age range.
We further explored chimpanzee-specific changes in the
H3K4me3 landscape of PFC neurons by comparing human and
chimpanzee peaks within the chimpanzee genome. To this end, we
constructed a mono-nucleosomal DNA library from chimpanzee
PFC to control for input, and mapped the neuronal H3K4me3
datasets from four chimpanzee PFC specimens, and their 11
human counterparts, to the chimpanzee genome (PT2). We
identified 551 peaks in the PT2 genome that were subject to .2-
fold gain and 337 peaks subject to .2-fold depletion, compared to
human regardless of the H3K4me3 level in macaque (Tables S7
and S8). A substantial portion of these PT2-annotated peaks (133
and 40 peaks, respectively) with gain or loss in chimpanzee PFC
neurons matched loci with the corresponding, reciprocal changes
specific to human PFC neurons in HG19 (410 and 61 peaks as
described above). Genetic differences among these genomes and
additional, locus-specific differences in nucleosomal organization
(leading to differences in background signal in the input libraries)
are potential factors that would lead to only partial matching of
peaks when species-specific H3K4me3 signals are mapped within
the human, or chimpanzee genome, respectively. These findings,
taken together, confirm that genome sequence differences in cis are
one important factor for the species-specific histone methylation
landscapes in PFC neurons.
Human-Specific H3K4me3 Peaks in PFC Neurons Overlap
with DNA Methylation Signatures in the Male Germline
Both catalytic and non-catalytic subunits of H3K4 methyltrans-
ferase complex are associated with transgenerational epigenetic
inheritance in the worm, Caenorhabditis elegans, and other simple
model organisms [17], and furthermore, H3K4me3 and other
epigenetic markings such as DNA cytosine methylation are readily
detectable in non-somatic (‘‘germline’’-related) cells such as sperm,
potentially passing on heritable information to human offspring
[18]. Therefore, we wanted to explore whether a subset of the 410
loci with at least 2-fold H3K4me3 enrichment in human neurons
are subject to species-specific epigenetic regulation in germ tissue.
To this end, we screened a human and chimpanzee sperm
database on DNA methylation [19], in order to find out which, if
any of the 410 sequences with human-specific H3K4me3 gain in
brain overlap with a set of.70,000 sequences defined by very low,
or non-detectable DNA methylation in human and chimpanzee
sperm (termed (DNA) ‘‘hypomethylated regions’’ in [19]). Of note,
the genome-wide distribution of H3K4me3 and DNA cytosine
methylation is mutually exclusive in germ and embryonic stem
cells, and gains in DNA methylation generally are associated with
loss of H3K4me3 in differentiated tissues [20,21]. Unsurprisingly
therefore, 300/410 HP peaks in brain matched a DNA
hypomethylated sequence in sperm of both species. Strikingly,
however, 90/410, or approximately 22% of HP were selectively
(DNA) hypomethylated in human but not in chimpanzee sperm
(Table S3), a ratio that is approximately 4-fold higher than the
expected 5.7% based on 10,000 simulations (p,0.00001; see also
Text S1) (Figure 1B). Conversely, the portion of HP lacking DNA
hypomethylation in male germ cells of either species altogether
(18/410 or 4%), or with selective hypomethylation in chimpanzee
Figure 1. Human-specific signatures of the neuronal epigenome in PFC. (A) Pearson correlation coefficients (R, mean 6 standard deviation
[SD]) for sample-to-sample comparison of H3K4me3 ChIP-seq normalized tag counts within Refseq promoters, revealing cell type- and species-
specific signatures. (B) Expected (blue)/observed (red) counts of human-specific H3K4me3 peaks (n= 410) overlapping with DNA hypomethylated
regions in human (H)/chimpanzee (P) sperm. Notice 4-fold enrichment for loci with human-only (H+,P2) DNA hypomethylation in dataset [19]. (C)
The actual co-localization of human-specific H3K4me3 peaks (n=410) within 1- or 0.5-Mb genomic distance is 2–3-fold higher than expected (based
on average distribution of entire set of 34,639 H3K4me3 peaks *(**), p,1023(24). (D) Representative example of a TSS (PDE4DIP/Myelomegalin
(‘‘regulator of brain size’’) with species- and cell type-specific H3K4me3 profile. Genome browser tracks showing ChIP-seq H3K4me3 signal at PDE4DIP
(chromosome 1) locus, annotated to HG19/PT2/RM2 genomes as indicated. Green/blue/black tracks from PFC neuronal (NeuN+) nuclei of 11 humans/
four chimpanzees/three macaques as indicated. Red tracks, non-neuronal (NeuN2) human PFC nuclei. Notice much stronger PDE4DIP peaks in
human neurons.
doi:10.1371/journal.pbio.1001427.g001
Epigenome Mapping in Prefrontal Cortex
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sperm (2/410 or 0.5%), showed a significant, 5-fold underrepre-
sentation in our dataset (Figure 1B). Thus, approximately one-
quarter of the 410 loci with human-specific gain in histone
methylation in PFC neurons also carry species-specific DNA
methylation signatures in sperm, with extremely strong bias
towards human (DNA) hypomethylated regions (22%) compared
to chimpanzee-specific (DNA) hypomethylated regions (0.5%). In
striking contrast, fewer than ten of the 61 loci with human-specific
H3K4me3 depletion in PFC neurons showed species-specific
differences in sperm DNA methylation between species (six
human- and three chimpanzee-specific DNA hypomethylated
regions; Table S5).
H3K4 Methylation Sites with Human-Specific Gain
Physically Interact in Megabase-Scale Higher Order
Chromatin Structures and Provide an Additional Layer for
Transcriptional Regulation
We noticed that, at numerous chromosomal loci, HP tended to
group in pairs or clusters (Table S3). There were more than 245
(163) from the total of 410 HP spaced less than 1 (or 0.5) Mb apart,
which is a highly significant, 2- (or 3-) fold enrichment compared
to random distribution within the total pool of 34,639 peaks
(Figure 1C; Text S1). Therefore, sequences with human-specific
gain in H3K4me3 in PFC neurons appear to be co-regulated with
neighboring sequences on the same chromosome that are
decorated with the same type of histone modification. Likewise,
the actual number of human-depleted peaks within one 1 Mb
(n=6) was higher than what is expected from random distribution
(n=2.6), (p=0.051), albeit no firm conclusions can be drawn due
to the smaller sample size (n=61).
This type of non-random distribution due to pairing or
clustering of the majority of human-enriched sequences broadly
resonates with the recently introduced concept of Mb-sized
topological domains as a pervasive feature of genome organiza-
tion, including increased physical interactions of sequences
carrying the same set of epigenetic decorations within a domain
[22]. Of note, H3K4 trimethylation of nucleosomes is linked to the
RNA polymerase II transcriptional initiation complex, and sharply
increased around TSS and broadly correlated with ‘‘open
chromatin’’ and gene expression activity [5,6]. Therefore, we
reasoned that a subset of human-enriched ‘‘paired’’ H3K4me3
peaks could engage in chromatin loopings associated with
transcriptional regulation. This is a very plausible hypothesis
given that promoters and other regulatory sequences involved in
transcriptional regulation are often tethered together in loopings
and other higher order chromatin [23,24].
To explore this, we screened a database obtained on chromatin
interaction analysis by paired-end tag sequencing (ChIA-PET) for
RNA polymerase II, a technique designed to detect chromosomal
loopings bound by the Pol II complex [25]. Indeed, we identified
at least three interactions that matched to our H3K4me3 peaks
with human-specific gain in PFC neurons (Table S9), including a
loop interspersed by approximately 2.5 Mb of sequence in
Figure 2. H3K4me3 landscapes and higher order chromatin at the psychiatric susceptibility locus, 16p11.2. (Top) UCSC genome
browser window track for approximately 1 Mb of human chr16: 21,462,663–22,499,013, with H3K4me3 ChIP-seq tracks from neuronal chromatin
(PFC) of three primate species, as indicated. Notice human-enriched H3K4me3 peaks at chr16:21,512,663–21,514,196 and chr16:22,448,157–
22,449,013 (marked by arrows) flanking numerous peaks common to all 3 species. (Bottom) Rectangles and thin arrows mark 3C HindIII restriction
fragments and primers from 3C assays. Notice positive interaction of sequences captured by primers 2 and 7, agarose gels shows representative 196-
bp PCR product for 3C from two PFC specimens (a,b), HEK cells, and no ligase and water controls.
doi:10.1371/journal.pbio.1001427.g002
Epigenome Mapping in Prefrontal Cortex
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chromosome 16p11.2–12.2. This is a risk locus for microdeletions
that are linked to a wide spectrum of neurodevelopmental disease
including autism spectrum disorder (ASD), intellectual disability
(ID), attention deficit hyperactivity disorder (ADHD), seizures,
and schizophrenia [26–31]. We were able to validate this
interaction by chromosome conformation capture (3C), a
technique for mapping long range physical interactions between
chromatin segments [32], in 2/2 human PFC specimens and also
in a human embryonic kidney (HEK) cell line (Figure 2). We
conclude that human-specific H3K4me3 peaks spaced as far
apart as 1 Mb are potentially co-regulated and physically interact
via chromatin loopings and other higher order chromatin
structures.
Neuronal Antisense RNA LOC389023 Originating from a
DPP10 (Chromosome 2q14) Higher Order Chromatin
Structure Forms a Stem-Loop and Interacts with
Transcriptional Repressors
Next, we wanted to explore whether sequences with human-
specific gain in histone methylation, including those that show
evidence for pairing and physical interactions, could affect the
regulation of gene expression specifically in PFC neurons. To this
end, we first identified which portion from the total of 410 human-
specific peaks showed much higher H3K4me3 levels selectively in
PFC neurons, when compared to their surrounding non-neuronal
cells in the PFC. Thus, in addition to the aforementioned filter
Figure 3. H3K4me3 landscapes and higher order chromatin at DPP10 (2q14.1). (A) (Top) Genome browser tracks showing ChIP-seq
H3K4me3 signal at DPP10 locus annotated to HG19 and RM2 genomes. Data expressed as normalized tag densities, averaged for 11 humans, four
chimpanzees, and three macaques as indicated (see also Figure S1 for comparative annotation for each of the 18 specimens in HG19 at DPP10/2q14.1,
and for the non-human primates also for the homologous loci in their respective genomes, PT2 and RM2). Human-specific peak DPP10-1 (1,455 bp)
and DPP10-2 (3,808 bp) marked by arrows and shown at higher resolution in boxes, as indicated. (Bottom) Rectangles and arrows mark Hind III
restriction fragments and primers from DPP10-1/2 (PK1, 2) and control regions (CR1-3) for 3C assays (human). Dotted lines connect primer pairs with
sequence-verified product, indicating physical interaction of the corresponding fragments. Agarose gels for representative PCR products from 3C
with (+) or without (2) DNA ligase (human primers 6,17: 282 bp; 6,18: 423 bp; 8,15: 160 bp; 9,15: 130 bp). (B) Rectangles and arrows mark Hind III
restriction fragments and primers for corresponding DPP10 sequences in RM2, for macaque brain 3C. Macaque primers 6,12:298 bp, 8,12:154 bp.
Notice positive interaction of PK1 with PK2 and neighboring CR2, but with not CR1 or CR3. Notice no signal in PFC 3C assays without DNA ligase and
no signal in all 3C assays from H9 pluripotent (H9ESC) and differentiated (DIFF) cell cultures.
doi:10.1371/journal.pbio.1001427.g003
Epigenome Mapping in Prefrontal Cortex
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criteria (2-fold increase in human PFC neurons compared to non-
human primate PFC neurons), we searched for peaks with
differential regulation among PFC neurons and non-neurons (see
Text S1). We found 33 HP with selective enrichment in neuronal
PFC chromatin (termed neuHP in the following) (Figure S1; Table
S10). Among these were two HP spaced less than 0.5 Mb apart
within the same gene, DPP10 (chr2q14.1), encoding a dipeptidyl
peptidase-related protein regulating potassium channels and
neuronal excitability (Figure 3A–3B) [33]. Interestingly, rare
structural variants of DPP10 confer strong genetic susceptibility
to autism, while some of the gene’s more common variants
contribute to a significant risk for bipolar disorder, schizophrenia,
and asthma [34–36]. Histone methylation at DPP10 was highly
regulated in species- and cell type-specific manner, with both
DPP10-1 and DPP10-2 peaks defined by a very strong H3K4me3
signal in human PFC neurons (Figure 3A), but only weak or non-
detectable peaks in their surrounding NeuN2 (non-neuronal)
nuclei (Figure S1; Table S10) or blood-derived epigenomes [7].
We then employed 3C assays across 1.5 Mb of the DPP10
(chr2q14.1) in PFC of four humans. To increase the specificity in
each 3C PCR assay, we positioned both the forward and reverse
primer in the same orientation on the sense strand, and samples
Figure 4. Novel transcripts and regulatory motifs at the DPP10 locus. (A) (top) DPP10 and LOC389023, extracted from published RNA-seq
datasets from human/chimpanzee/macaque PFC [40]. (Bottom) shows 3.8-kb DPP10-2 bidirectional promoter, blue tick marks for human-specific
sequence divergence from five other anthropoid primates (Table S12), including (from left to right) SNP rs35809114, and fixed polymorphism with
novel CTF/CBP motif not found in archaic hominins (H. denisova, H. neanderthalensis) and novel GATA-1 motif within highly conserved sequence
across many mammalian lineages (Table S17). The vertical dotted red line marks the potential center of an adaptive fixation in modern humans (see
text). (B) Bar graphs summarize qRT-PCR on PFC RNA showing much higher LOC389023 in human, and lower expression of DPP10 exons downstream
of DPP10-2 peak (Figure 4A). *(**) p,0.05 (0.01). (C) (Left) GATA-1 consensus motifs/binding affinities (http://snpper.chip.org/mapper). (Right) HeLa
nuclear extract (NE) gel shifts with 32P-labeled 21 bp duplex probes for human (H) and chimpanzee (P) sequences encompassing GATA-1 motif as
indicated. (Left gel) lanes (1,2,5,6) labeled probe, (3,7) cold competitor, (4,8) unrelated duplex, or increasing salt concentrations as indicated. Anti-
GATA supershift assay confirms GATA-1 protein binding to probe sequence.
doi:10.1371/journal.pbio.1001427.g004
Epigenome Mapping in Prefrontal Cortex
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processed for 3C while omitting the critical DNA ligation step
from the protocol served as negative control (Figure 3A–3B).
Indeed, 3C assays on four of four human PFC specimens
demonstrated direct contacts between the DPP10-1 and -2 peaks
(Figure 3A). As expected for neighboring fragments [32], DPP10-1
also interacted with portions of the interspersed sequence (CR2 in
Figure 3A). These interactions were specific, because several other
chromatin segments within the same portion of chr2q14.1 did not
show longer range interactions with DPP10-1 (CR1, CR3 in
Figure 3A). We further verified one of the DPP10-1/2 physical
interactions (the sequences captured by primers 6 and 17 in
Figure 3A) in four of five brains using 3C-qPCR with a TaqMan
probe positioned in fragment 6. Furthermore, DPP10-2 interacted
with a region (‘‘CR3’’ in Figure 3A) 400 kb further downstream
positioned in close proximity to a blood-specific H3K4me3 peak.
No interactions at the DPP10 locus were observed in cultured cells
derived from the H9 embryonic stem cell line (H9ESC in
Figure 3A), suggesting that these chromatin architectures are
specific for differentiated brain tissue. Of note, similar types of
DPP10 physical interactions were found in 3C assays conducted on
PFC tissue of three of three macaques (Figure 3B). Because
macaque PFC, in comparison to human, shows much weaker
H3K4 methylation at these DPP10 sequences, we conclude that
the corresponding chromatin tetherings are not critically depen-
dent on human-specific H3K4me3 dosage.
Next, we wanted to explore whether human-specific H3K4
methylation at the DPP10 locus is associated with a corresponding
change in gene expression at that locus. Notably, H3K4me3 is on
a genome-wide scale broadly correlated with transcriptional
activity, including negative regulation of RNA expression by
generating very short (,50–200 nt) promoter-associated RNAs.
These short transcripts originate at sites of H4K4me3-tagged
nucleosomes and act as cis-repressors in conjunction with
polycomb and other chromatin remodeling complexes [37,38].
Therefore, transcriptional activities due to the emergence of novel
H3K4me3 markings in human PFC is likely to be complex, with
unique functional implications specific to each genomic locus. To
explore the transcriptome at the DPP10 locus in an unbiased
manner, we performed RNA-seq on a separate cohort of three
adult human PFC (not part of the aforementioned ChIP-seq
studies) and compared their transcriptional landscapes to similar
datasets from chimpanzee and macaque [39,40]. Indeed, we found
an antisense RNA, LOC389023, emerging from the second DPP10
peak, DPP10-2 (chr2q14.1) (Figures 3A and 4A). In an additional
independent analyses (using a set of human postmortem brains
different from the ones used for RNAseq) quantitative reverse
transcriptase (RT)-PCR assays further validated the much higher
expression of DPP10 antisense transcript in human (Figure 4B),
which occurred in conjunction with decreased expression of
DPP10 exons downstream of the DPP10-2 promoter (compared to
chimp/macaque) (Figure 4A).
Consistent with the H3K4me3 enrichment specifically in
neuronal chromatin, the cellular expression of LOC389023 in
adult PFC was confined to a subset of the neuronal layers (II–IV),
but absent in neuron-poor compartments such as layer I and
subcortical white matter (Figure 5A and unpublished data).
Furthermore, the transcript was expressed in fetal and adult
PFC but not in cerebellar cortex (Figure 5B). We noticed that
LOC389023 harbored a GC-rich stem loop motif that is known to
associate with cis-regulatory mechanisms involved in transcrip-
tional repression, including binding to TSS chromatin and
components of Polycomb 2 (PRC2) complex (Figure 5C) [37,41].
Figure 5. Cellular distribution and molecular affinities of human-specific RNA, LOC389023. (A) Digitized images of sections from adult
human PFC, stained with (left to right) Nissl, b-actin, LOC389023, and negative control (nc). Notice numerous LOC389023-expressing cells in cortical
layers II–IV but not in neuron-poor layer I. (B) (Top) LOC389023, and for loading control, 18S rRNA PCR from nuclear (Nuc) and cytosolic (Cyto) RNA
extracts, showing robust LOC389023 expression in nuclear fraction but not cytosolic of a prenatal (around 35 wk of gestation) PFC specimen. No
LOC389023 expression was found in fetal cerebellum. (Bottom) PCR from nuclear RNA isolates of adult PFC specimens and of HEK cell line. Notice
weak signal in neurodegenerative Alzheimer PFC specimen, no signal in peripheral (HEK) cells, and strong signal in PFC nuclei from normal adult
controls. (C) GC rich stem loop of LOC389023 (see text). (D) RT-PCR for LOC389023 from (top) pulldowns of transfected neuroblastoma cells, (left to
right) IgG, H3K4-trimethylated nucleosomal preparation co-incubated with or without dimethyl-H3K4-blocking peptide, anti-EZH2, anti-SUZ12, and
(bottom) input loading control. Notice specific affinity of LOC389023 for H3K4me3 and SUZ12.
doi:10.1371/journal.pbio.1001427.g005
Epigenome Mapping in Prefrontal Cortex
PLOS Biology | www.plosbiology.org 7 November 2012 | Volume 10 | Issue 11 | e1001427
Consistent with a possible function inside the nucleus, LOC389023
was highly enriched in nuclear RNA fractions from extracted
prenatal and normal (non-degenerative) adult human PFC, but
not cerebellar cortex (Figure 5B). Indeed, in transiently transfected
(human) SK-N-MC neuroblastoma cells, LOC389023 showed a
specific association with H3K4-trimethylated nucleosomes and
SUZ12 (Figure 5D), a zinc finger protein and core component of
PRC2 previously shown to interact with stem loop motifs similar
to the one shown in Figure 5C [37]. In contrast, EZH2, a (H3K27)
methyltransferase and catalytic component of PRC-2, did not
interact with LOC389023 (Figure 5D), consistent with previous
reports on other RNA species carrying a similar stem loop motif
[37]. These observations, taken together, are entirely consistent
with the aforementioned findings that levels of DPP10 transcript,
including exons positioned downstream of the DPP10-2 peak from
which LOC389023 originates, are significantly decreased in human
PFC as compared to macaque and chimpanzee. Conversely, these
two primates show non-detectable (RNAseq) or much lower
quantitative RT-PCR (qRT-PCR) LOC389023 levels in the PFC,
as compared to human (Figure 4A–4B). Taken together then,
these findings strongly suggest that LOC389023 emerged de novo
in human PFC neurons and interacts with localized chromatin
templates to mediate transcriptional repression at the DPP10 locus
(Figure 6).
Association of Human-Specific H3K4-Methylation Sites
with Disease
The aforementioned human-specific gains in histone methyla-
tion at DPP10 and the emergence of human RNA de novo at this
locus could reflect a phylogenetically driven reorganization of
neuronal functions that may have contributed not only to the
emergence of human-specific executive and social-emotional
functions, but also for increased susceptibility for developmental
brain disease [42]. In this context, we noticed that the 33 neuHP
(which are defined by two criteria which are (i) human-specific
gain compared to non-human primates and (ii) high H3K4me3 in
PFC neurons but not their surrounding non-neuronal cells)
included multiple genes conferring susceptibility to neurological
disease. Three loci, including DPP10 on chromosome 2q14.1 and
two genes in close proximity on chromosome 3p26.3, CNTN4 and
CHL1, both encoding cell adhesion molecules [34,43–45], confer
very strong susceptibility to autism, schizophrenia, and related
disease. Other disease-associated loci with human-specific gain
selectively in PFC neurons include ADCYAP1, a schizophrenia
[46,47] and movement disorder gene [48] that is part of a cAMP-
activating pathway also implicated in posttraumatic stress [49].
PDE4DIP (MYOMEGALIN) (Figure 1D) encodes a centrosomal
regulator of brain size and neurogenesis [50] that in some studies
was 9-fold higher expressed in human as compared to chimpanzee
cortex [51,52]. SORCS1 is implicated in beta amyloid processing
and Alzheimer disease [53,54] and attention deficit hyperactivity
disorder [55], which again are considered human-specific neuro-
logical conditions [10]. Because four of 33, or 12% of neuHP
overlapped with neurodevelopmental susceptibility genes (CNTN4,
CHL1, DPP10, SORCS1), we then checked whether the entire set of
410 human-specific peaks is enriched for genes and loci conferring
genetic risk for autism, intellectual disability, and related
neurological disease with onset in early childhood. However,
there was only minimal overlap with the Simons Foundation
Autism Research Initiative database (SFARI) [56], and Human
unidentified Gene Encoded protein database (HuGE) for pervasive
developmental disorder (including autism) associated polymor-
phism [57], and recent reference lists for mental retardation and/
or autism-related genes (each of these databases five or fewer of the
human-enriched peaks) [58]. Likewise, there was minimal, and
non-significant overlap with the set of 61 human- and 337
chimpanzee-depleted peaks, or the 551 chimpanzee-enriched in
PFC neurons (five or fewer of peaks/database). None of the lists of
peaks with human- or chimpanzee-specific gain or loss of
H3K4me3 revealed statistical significance for any associations
with the Gene Ontology (GO) database. We conclude that DNA
sequences subject to differential histone methylation in human or
chimpanzee PFC neurons are, as a group, not clustered together
into specific cellular signaling pathways or functions. Table 1
presents examples of disease-associated genes associated with
human-specific gain, or loss of H3K4-trimethylation.
Evolutionary Footprints at Sites Defined by Human-
Specific Histone Methylation
We then asked whether the subset of DNA sequences with
species- and cell type-specific epigenetic regulation, including the
neuHP peaks mentioned above carry a strong footprint of hominid
evolution. Indeed, nucleotide substitution analysis revealed that
both DPP10 peaks DPP10 -1/2, as well as ADCYAP1, CHL1,
CNTN4, NRSN2, and SIRPA show a significantly elevated rate,
with 2- to 5-fold increase specifically in the human branch of the
primate tree, when compared to four other anthropoid primate
species (Pan troglodytes, Gorilla gorilla, Pongo abelii, Macaca mulatta)
(Table S11). The finding that both DPP10 peaks, DPP10-1 and -2
showed a significant, .4-fold increase in nucleotide substitution
rates in the human branch of the primate tree—indicating ‘‘co-
evolution’’ (or coordinated loss of constraint)—is very plausible
given that chromatin structures surrounding these DNA sequences
are in direct physical contact (discussed above), reflecting a
Figure 6. Hypothetical mechanism of action of novel human-
specific RNA, LOC389023. (Top) In non-human primate, DPP10
transcripts are expressed by the RNA polymerase II complex from the
DPP10-2 promoter (see text) that is tagged with H3K4me3. (Bottom) In
human, there is specific gain of H3K4me3 signal particularly in the 59
portion of the DPP10-2 promoter (see text), which is associated with a
novel antisense RNA, LOC389023. This RNA recruits Polycomb 2(PRC2)
and other transcriptional repressors in cis, thereby inhibiting expression
of the sense transcript, DPP10.
doi:10.1371/journal.pbio.1001427.g006
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potential functional interaction and shared regulatory mechanisms
between peaks.
To further confirm the role of phylogenetic factors in the
emergence of human-specific H3K4me3 peaks, we focused on the
set of 33 neuHP and calculated the total number of human-specific
sequence alterations (HSAs), in a comparative genome analyses
across five primates (H. sapiens, P. troglodytes, G. gorilla, P. abelii, M.
mulatta). We recorded altogether 1,519 HSAs, with.90% as single
Table 1. Examples of disease-associated genes with human-specific gain or loss of H3K4 trimethylation in PFC neurons.
Gene;
Location; HGNC Gene
H3K4me3 Change
in Human Disease Association
Function in the Forebrain,
Including Cerebral Cortex
ADCYAP1; 18p11.32;
241
adenylate cyclase activating
polypeptide 1
Gain Schizophrenia [46,47],
movement disorder [48],
PTSD [49]
Alternate camp signaling pathway,
mediates synaptic plasticity and LTD in
hippocampus [95]
CACNA1C; 12p13.33;
1390
calcium channel, voltage-dependent,
L type, alpha 1C subunit
Gain Confers genetic risk for
mood, psychosis, and autism
spectrum disorders [96,97]
Coupling of cell membrane
depolarization to transient increase of
membrane permeability for calcium [96]
CHL1; 3p26.3;
1939
cell adhesion molecule with
homology to L1CAM
Gain Autism, schizophrenia
[35,44–46]
Thalamocortical axon guidance via
interaction with ephrin receptors [98,99]
CNTN4; 3p26.3;
2174
contactin 4 Gain Autism, intellectual
disability [34,43–45]
Developmental patterning of functional
odor maps in olfactory bulb, axon-
associated cell adhesion molecule
[34,43–45]
DGCR6; 22q11.21;
2844
DiGeorge syndrome critical
region gene 6
Gain Autism, schizophrenia
[74,75]
Regulates intracellular distribution of
GABAB receptor [100]
DPP10; 2q14.1;
20823
dipeptidyl-peptidase 10 Gain Autism, mood disorder,
schizophrenia, asthma
[34–36]
Regulation of neuronal excitability as
auxiliary subunit of potassium channels
[33]
FOXP2; 7q31.1;
13875
forkhead box P2 Loss Speech and language disorder
with subtle structural and
functional changes in brain
circuitry [81,82]
Transcription factor regulating gene
expression programs in vocal
communication, including human
speech and birdsong [82,101,102]
LMX1B; 9q33.3;
6654
Lim homeobox
transcription factor 1, beta
Loss ADHD and depression
[103]
Key control point in gene expression
programs for dopaminergic and
serotonergic neurons [104,105]
NOTCH4; 6p21.3;
7884
neurogenic locus notch
homolog gene 4
Gain Schizophrenia
[106,107]
Endothelial Notch 4 regulates brain
vasculature [108]
PDE4DIP; 1q21.1;
15580
phoshodiesterase 4D
Interacting protein
Gain Altered phospho-diesterase
signaling broadly relevant for
mood and psychosis spectrum
disorders [109,110]
Anchor protein for cAMP pathway in
the Golgi/centrosomal complex,
homologue to drosophila centrosomin
regulating brain development and
implicated in neurogenesis [50,111]
SLC2A3; 12p13.31;
11007
solute carrier family 2
(facilitated glucose transporter),
member 3
Gain Dyslexia, ADHD
[78,79]
Neuronal glucose transporter, highly
expressed in neuronal processes and
synaptic structures and neuropil of
human cerebral cortex and other brain
regions [112,113]
SORCS1; 10q25.1;
16697
sortilin-related VPS10 domain
containing receptor 1
Gain ADHD [54] In a complex with pro-NGF, involved in
NGF-mediated cell signaling and
neuroapoptosis [114]. Interacts, like
other sortilins, with gamma-secretase
implicated in Alzheimer disease [54]
TRIB3; 20p13;
16228
tribbles homolog 3
pseudo-kinase
Gain Genetic determinant for
information-processing speed
in human [115] and insulin-
dependent diabetes [116]
Competes in complex with ATF4 with
CREB transcription factor to regulate
expression of synaptosomal-associated
protein 25 (SNAP-25) involved in insulin
exocytosis and neurotransmission [116]
TUBB2B; 6p25.2;
30829
class IIb beta-tubulin Gain Cortical malformations
including poly-microgyria
[117], microcephaly, seizures,
intellectual disability [118]
Essential for neuronal migration and
other functions of the microtubuli
complex [80]
ZNF423; 16p12.1;
16762
zinc-finger protein 423 Loss 16q12 microdeletion
syndrome with micro-cephaly
and dysmorpho-genesis of
fore- and hindbrain [119,120]
C2H2-type zinc finger transcription
factor that controls the switch to
neuronal maturation during olfactory
neurogenesis [121] and axonal
projections across forebrain
commissures [122].
ADHD, attention deficit hyperactivity disorder; LTD, long-term depression; NGF, nerve growth factor; PTSD, post-traumatic stress disorder.
doi:10.1371/journal.pbio.1001427.t001
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nucleotide substitutions, five .100 bp INDELs, one (Alu) retro-
transposon-like element at TRIB3 pseudokinase consistent with a
role of mobile elements in primate evolution [3], and gain or loss
of hundreds of regulatory motifs (Table S12). When compared to a
group of (neuronal) H3K4me3 peaks showing minimal changes
between the three primate species (Table S13), the neuHP, as a
group, showed a significant, 2.5-fold increase in the number of
HSA (20.0865.52 HSAs versus 8.3662.44 HSAs per 1-kb
sequence, p=2.4e206, Wilcoxon rank sum test; Figure S3). The
findings further confirm that genetic differences related to
speciation indeed could play a major role for changes in the
brain’s histone methylation landscape, particularly for H3K4me3
peaks that are highly specific for human neurons (neuHP).
Interestingly, none of the above loci showed evidence for
accelerated evolution of neighboring protein coding sequences
(Table S11), reaffirming the view that protein coding sequences for
synaptic and other neuron-specific genes are extremely conserved
across the primate tree [1,2].
These DNA sequence alterations at sites of neuron-restricted
H3K4me3 peaks (with human-specific gain) point, at least for this
subset of loci, to a strong evolutionary footprint before the split of
human–chimpanzee lineage several million years ago [3]. Next,
we wanted to find out whether there is also evidence for more
recent selective pressures at these loci. Indeed, a subset of neuHP
contain H. sapiens-specific sequences not only absent in rodents,
anthropoid primates, but even in extinct members of the genus
homo, including H. neanderthalensis and H. denisova [59]. Some of the
ancestral alleles (including MIAT, SIRPA, NRSN) shared with
archaic hominins exhibit very low frequencies at 0%–3% in all
modern populations, and therefore it remains possible that positive
selection for newly derived alleles contributed to their high
population frequencies in modern humans (Table S14). However,
for the entire set of neuHP that are defined by high H3K4me3 levels
in PFC neurons (but not non-neurons), the number of HSAs that
emerged after the human lineage was split from H. denisova or H.
neanderthalensis were 3.31% and 1.75%, respectively, which is
approximately 2-fold lower as compared to 32 control H3K4me3
peaks with minimal differences among the three primate species
(5.03% and 3.77%). The 2-fold difference in the number of H.
sapiens-specific alleles (neuHP compared to control peaks) showed a
strong trend toward significant (p=0.067) for the Denisova, and
reached the level of significance (p=0.034) for the Neanderthal
genome (based on permutation test with 10,000 simulations [60]).
Taken together, these results suggest that at least a subset of the
TSS regions with H3K4me3 enrichment in human (compared to
non-human primates) were exposed to evolutionary driven DNA
sequence changes on a lineage of the common ancestor of H.
sapiens and the archaic hominins, but subsequently were stabilized
in more recent human evolution, after splitting from other
hominins.
To further test whether or not there were recent, perhaps even
ongoing selective pressures at loci defined by human-specific gain
in H3K4me3 peaks of PFC neurons, we searched for overlap
among the peaks in our study with hundreds of candidate regions
in the human genome showing evidence of selection during the
past 10–100,000 years from other studies. These loci typically
extend over several kb, and were identified in several recent studies
on the basis of criteria associated with a ‘‘selective sweep,’’ which
describes the elimination of genetic variation in sequences
surrounding an advantageous mutation while it becomes fixed
[61–64]. However, screening of the entire set of 410 human gain
and 61 human depleted H3K4me3 sequences against nine datasets
for putative selection in humans [65] revealed only five loci with
evidence for recent sweeps (Table S15). One of these matched to
the neuHP on chromosome 2q14.1, corresponding to the second
DPP10 (DPP10-2) peak (see above). In independent analyses, using
the 1,000 genome database, we further confirmed recent adaptive
fixations around DPP10-2 (Table S16), as well as two other loci,
POLL and TSPAN4. While it is presently extremely difficult to
determine how much of the genome has been affected by positive
selection (of note, a recent metanalysis of 21 recent studies using
total genomic scans for positive selection using human polymor-
phism data revealed unexpectedly minimal overlap between
studies [65]), we conclude that the overwhelming majority of loci
associated with human-specific H3K4me3 gain or loss in PFC
neurons (compared to non-human primates) indeed does not show
evidence for more recent selective pressures.
To provide an example on altered chromatin function due to an
alteration in a regulatory DNA sequence that occurred after the
human lineage split from the common ancestor with non-human
primates, we focused on a change in a GATA-1 motif (A/
TGATTAG) within a portion of DPP10-2 found in human, within
an otherwise deeply conserved sequence across many mammalian
lineages (Table S17). Gel shift assays demonstrate that the human-
specific sequence harboring the novel GATA-1 site showed much
higher affinity to HeLa nuclear protein extracts, compared to the
chimpanzee/other mammal sequence (Figure 4C). The emergence
of a novel GATA-1 motif at DPP10 is unlikely to reflect a systemic
trend because the motif overall was lost, rather than gained in
neuHP (10/355 versus 4/375, x2 p=0.053). Therefore, evolution-
ary and highly specific changes in a small subset of regulatory
motifs at DPP10 and other loci could potentially result in profound
changes in nuclear protein binding at TSS and other regulatory
sequences, thereby affecting histone methylation and epigenetic
control of gene expression in humans, compared to other
mammals including monkeys and great apes. Of note, potentially
important changes in chromatin structure and function due to
human-specific sequence alterations at a single nucleotide within
an otherwise highly conserved mammalian sequence will be
difficult to ‘‘capture’’ by comparative genome analyses alone. For
example, when the total set of 410 HP was crosschecked against a
database of 202 sequences with evidence for human-specific
accelerated evolution in loci that are highly conserved between
rodent and primate lineages [66], only one of 410 HP matched
(Table S15).
Species-Specific Transcriptional Regulation
H3K4me3 is a transcriptional mark that on a genome-wide scale
is broadly associated with RNA polymerase II occupancies and
RNA expression [67]. However, it is also associated with repressive
chromatin remodeling complexes and at some loci the mark is
linked to short antisense RNAs originating from bidirectional
promoters, in conjunction with negative regulation of the (sense)
gene transcript [37,38]. Indeed, this is what we observed for the
DPP10 locus (Figure 6). Therefore, a comprehensive assessment of
all transcriptional changes associated with the evolutionary alter-
ations in H3K4me3 landscape of PFC neurons would require deep
sequencing of intra- and extranuclear RNA, to ensure full capture of
short RNAs and all other transcripts that lack polyadenylation and/
or export into cytoplasm. While this is beyond the scope of the
present study, we found several additional examples for altered
RNA expression at the site of human-specific H3K4me3 change.
There were four of 33 neuHP loci associated with novel RNA
expression specific for human PFC, including the aforementioned
DPP10 locus. The remaining three human-specific transcripts
included two additional putative non-coding RNAs,
LOC421321(chr7p14.3) and AX746692 (chr17p11.2). There was
also a novel transcript for ASPARATE DEHYDROGENASE
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ISOFORM 2 (ASPDH)(chr19q13.33) (Figure S2). Furthermore, a
fifth neuHP, positioned within an intronic portion of the tetraspanin
gene TSPAN4 (chr11p15.5), was associated with a dramatic, human-
specific decrease of local transcript, including the surrounding exons
(Figure S2). Comparative analyses of prefrontal RNA-seq signals for
the entire set of the 410 HP included at least 18 loci showing a
highly consistent, at least 2-fold increase or decrease in RNA levels
of human PFC, compared to the other two primate species (Table
S18).
Discussion
In the present study, we report that on a genome-wide scale,
471 loci show a robust, human-specific change in H3K4me3 levels
at TSS and related regulatory sequences in neuronal chromatin
from PFC, in comparison to the chimpanzee and macaque.
Among the 410 sequences with human-specific gain in histone
methylation, there was a 4-fold overrepresentation of loci subject
to species-specific DNA methylation in sperm [19]. This would
suggest that there is already considerable ‘‘epigenetic distance’’
between the germline of H. sapiens and non-human primates
(including the great apes), which during embryonic development
and tissue differentiation is then ‘‘carried over’’ into the brain’s
epigenome. The fact that many loci show species-specific
epigenetic signatures both in sperm [19] and PFC neurons
(Figure 1B) raises questions about the role of epigenetic inheritance
[68] during hominid evolution. However, to further clarify this
issue, additional comparative analysis of epigenetic markings in
brain and germline will be necessary, including histone methyl-
ation maps from oocytes, which currently do not exist. However,
the majority of species-specific epigenetic decorations, including
those that could be vertically transmitted through the germline,
could ultimately be driven by genetic differences. On the basis of
DNA methylation analyses in three-generation pedigrees, more
than 92% of the differences in methylcytosine load between alleles
are explained by haplotype, suggesting a dominant role of genetic
variation in the establishment of epigenetic markings, as opposed
to environmental influences [69]. A broad overall correlation
between genetic and epigenetic differences was also reported in a
recent human–chimpanzee sperm DNA methylation study [19],
and there is general consensus that the inherent mutability of
methylated cytosine residues due to their spontaneous deamina-
tion to thymine is one factor contributing to sequence divergence
at CpG rich promoters with differential DNA methylation
between species [19,70]. Furthermore, human-specific sequences
in the DNA binding domains of PRDM9, which encodes a rapidly
evolving methyltransferase regulating H3K4me3 in germ cells,
were recently identified as a major driver for human–chimpanzee
differences in meiotic recombination and genome organization
[71]. It will be interesting to explore whether PRDM9-dependent
histone methyltransferase activity was involved in the epigenetic
regulation of the human-enriched H3K4me3 peaks that were
identified in the present study.
Another interesting finding that arose from the present study
concerns the non-random distribution of histone methylation peaks
with human-specific gain, due to a significant, 2- to 3-fold
overrepresentation of peak-pairing or -clustering on a 500 kb to
1 Mb scale. This result fits well with the emerging insights into the
spatial organization of interphase chromosomes, including the
‘‘loopings,’’ ‘‘‘tetherings’’ and ‘‘globules’’ that bring DNA sequences
that are spatially separated on the linear genome into close physical
contact with each other [72]. Specifically, many chromosomal areas
are partitioned into Mb-scale ‘‘topological domains’’, which are
defined by robust physical interaction of intra-domain sequences
carrying the same set of epigenetic decorations [22]. These
mechanisms could indeed have set the stage for coordinated genetic
and epigenetic changes during the course of hominid brain
evolution. The DPP10 (2q14.1) neurodevelopmental susceptibility
locus provides a particularly illustrative example: here, two
H3K4me3 peak sequences with strong human-specific gain were
separated by hundreds of kilobases of interspersed sequence, yet
showed a strikingly similar, 4-fold acceleration of nucleotide
substitution rates specifically in the human branch of the primate
tree. Importantly, the two H3K4me3 peaks, DPP10-1 and -2, as
shown here, are bundled together in a loop or other types of higher
order chromatin. Therefore, our findings lead to a complex picture
of the human-specific shapings of the neuronal epigenome,
including a mutual interrelation of DNA sequence alterations and
epigenetic adaptations involving histone methylation and higher
order chromatin structures. The confluence of these factors could
then, in a subset of PFC neurons (Figure 5A), result in the expression
of a novel antisense RNA, which associates with transcriptional
repressors to regulate the target transcript in cis, DPP10 (Figures 5D
and 6).
While the present study identified a few loci, including the
aforementioned DPP10 (chromosome 2q14.1), in which DNA
sequences associated with a human-specific gain in neuronal
histone methylation showed signs for positive selection in the
human population, it must be emphasized that the overwhelming
majority of sites with human-specific H3K4me3 changes did not
show evidence for recent adaptive fixations in the surrounding
DNA. Therefore, and perhaps not unsurprisingly, neuronal
histone methylation mapping in human, chimpanzee, and
macaque primarily reveals information about changes in epige-
netic decoration of regulatory sequences in the hominid genome
after our lineage split from the common ancestor shared with
present-day non-human primates.
Moreover, according to the present study, the subset of 33
sequences with human-specific H3K4me3 gain and selective
enrichment in neuronal (as opposed to non-neuronal) PFC
chromatin show a significant, 3-fold increase in human-specific
(DNA sequence) alterations in comparison to non-human primate
genomes. This finding speaks to the importance of evolutionary
changes in regulatory sequences important for neuronal functions.
Strikingly, however, the same set of sequences show a significant,
approximately 1.5- to 2-fold decrease in sequence alterations when
compared to the two archaic hominin (H. denisova, H. neanderthalensis)
genomes. This finding further reaffirms that sequences defined by
differential epigenetic regulation in human and non-human primate
brain, as a group, are unlikely to be of major importance for more
recent evolution, including any (yet elusive) genetic alterations that
may underlie the suspected differences in human and neanderthal
brain development [73]. However, these general conclusions by no
means rule out a critical role for a subset of human-specific sequence
alterations on the single nucleotide level within any of the HPs
described here, including the DPP10 locus.
Such types of single nucleotide alterations and polymorphisms
may be of particular importance at the small number of loci with
human-specific H3K4me3 gain that contribute to susceptibility of
neurological and psychiatric disorders that are unique to human
(though it should be noticed that as a group, the entire set of
sequences subject to human-specific gain, or loss, of H3K4me3 are
not significantly enriched for neurodevelopmental disease genes).
The list would not only include the already discussed ADYCAP1,
CHL1, CNTN4, and DPP10, which were among the narrow list of
33 human-specific peaks highly enriched in neuronal but not non-
neuronal PFC chromatin), but also DGCR6, an autism and
schizophrenia susceptibility gene [74,75] within the DiGeorge/
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Velocardiofacial syndrome/22q11 risk locus, NOTCH4 and
CACNA1C encoding transmembrane signaling proteins linked to
schizophrenia and bipolar disorder in multiple genome-wide
association studies [76,77], SLC2A3 encoding a neuronal glucose
transporter linked to dyslexia and attention-deficit hyperactivity
disorder [78,79] and the neuronal migration gene TUBB2B that
has been linked to polymicrogria and defective neurodevelopment
[80]. Furthermore, among the 61 peaks with human-specific loss
of H3K4me3 is a 700-bp sequence upstream of the TSS of FOXP2,
encoding a forkhead transcription factor essential for proper
human speech and language capabilities [81] and that has been
subject to accelerated evolution with amino acid changes leading
to partially different molecular functions in human compared to
great apes [82,83]. The homebox gene LMX1B is another
interesting disease-associated gene that is subject to human-
specific H3K4me3 depletion (Table 1). While expression of many
of these disease-associated genes is readily detectable even in
mouse cerebral cortex [84], the neuropsychiatric conditions
associated with them lack a correlate in anthropoid primates
and other animals. This could speak to the functional significance
of H3K4 methylation as an additional layer for transcriptional
regulation, with adaptive H3K4me3 changes at select loci and
TSS potentially resulting in improved cognition while at the same
time in the context of genetic or environmental risk factors
contribute to neuropsychiatric disease. More generally, our
findings are in line with a potential role for epigenetic
(dys)regulation in the pathophysiology of a wide range of
neurological and psychiatric disorders [85–88].
Our study also faces important limitations. While we used child
and adult brains for cross-species comparisons, human-specific
signatures in the cortical transcriptome are thought to be even
more pronounced during pre- and perinatal development [89].
Therefore, younger brains could show changes at additional loci,
or more pronounced alterations at the TSS of some genes
identified in the present study, including the above mentioned
susceptibility genes CNTN4 and myelomegalin/PDE4DIP, which
are expressed at very high levels in the human frontal lobe at
midgestation [90]. In this context, our finding that a large
majority, or 345 of 410 H3K4me3 peaks showed a human-specific
gain both in children and adults, resonates with Somel and
colleagues [11] who suggested that some of the age-sensitive
differences in cortical gene expression among primate species are
due to trans-acting factors such as microRNA,s while cis-regulatory
changes (which were the focus of the present study) primarily affect
genes that are subject to a lesser regulation by developmental
processes. More broadly, our studies supports the general view that
transcriptional regulation of both of coding and non-coding
(including antisense) RNAs could play a role in the evolution of the
primate brain [91].
Furthermore, the cell type-specific, neuronal versus non-
neuronal chromatin studies as presented here provide a significant
advancement over conventional approaches utilizing tissue
homogenate. However, pending further technological advances,
it will be interesting to explore genome organization in select
subsets of nerve cells that bear particularly strong footprints of
adaptation, such as the Von Economo neurons, a type of cortical
projection neuron highly specific for the hominid lineage of the
primate tree and other mammals with complex social and
cognitive-emotional skill sets [92]. Furthermore, our focus on
PFC does not exclude the possibility that other cortical regions
[93], or specialized sublayers such as within the fourth layer of
visual cortex that shows a complex transcriptional architecture
[94], show human-specific histone methylation gains at additional
TSS that were missed by the present study.
More broadly, the approach provided here, which is region-
and cell type-specific epigenome mapping in multiple primate
species, highlights the potential of epigenetic markings to identify
regulatory non-coding sequences with a potential role in the
context of hominid brain evolution and the shaping of human-
specific brain functions. Remarkably, a small subset of loci,
including the aforementioned DPP10 (chromosome 2q14.1), shows
evidence for ongoing selective pressures in humans, resulting in
DNA sequence alterations and the remodeling of local histone
methylation landscapes, after the last common ancestor of human
and non-human primates.
Materials and Methods
Text S1 contains detailed description for sample preparation for
ChIP-seq and RNA-seq, qRT-PCR, gel shift, and 3C assays
including primer sequences, RNA immunoprecipitation and in
situ hybridization, bioinformatics and analyses of deep sequencing
data, exploration of regulatory motifs, calculation of nucleotide
substitution rates in the primate tree, and sweep analyses for
polymorphic regions.
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